Agios Pharm (AGIO) Insider Trading
- $153,404,205.75
- $157,476,179.54
- July 10, 2025
- Scott Biller
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 1, 2018 | Insider | 2,000 | $78.75 | Sell | $157,500.00 | |
Feb. 1, 2018 | CEO | 13,000 | $78.75 | Sell | $1,023,750.00 | |
Jan. 26, 2018 | CEO | 23,572 | $81.09 | Sell | $1,911,453.48 | |
Jan. 24, 2018 | CEO | 46,408 | $80.01 | Sell | $3,713,104.08 | |
Jan. 23, 2018 | Major Shareholder | 851,154 | $67.00 | Buy | $57,027,318.00 | |
Jan. 23, 2018 | Insider | 25,000 | $74.83 | Sell | $1,870,750.00 | |
Jan. 16, 2018 | CEO | 53,000 | $73.16 | Sell | $3,877,480.00 | |
Jan. 12, 2018 | Insider | 2,150 | $75.00 | Sell | $161,250.00 | |
Jan. 10, 2018 | Insider | 3,000 | $65.00 | Sell | $195,000.00 | |
Dec. 7, 2017 | Director | 3,838 | $59.37 | Sell | $227,862.06 | |
Dec. 1, 2017 | Insider | 2,146 | $60.79 | Sell | $130,455.34 | |
Dec. 1, 2017 | CEO | 6,000 | $61.55 | Sell | $369,300.00 | |
Nov. 14, 2017 | Director | 4,000 | $60.88 | Sell | $243,520.00 | |
Nov. 1, 2017 | Insider | 2,146 | $62.69 | Sell | $134,532.74 | |
Nov. 1, 2017 | CEO | 6,000 | $63.85 | Sell | $383,100.00 | |
Oct. 17, 2017 | Director | 4,000 | $71.10 | Sell | $284,400.00 | |
Oct. 16, 2017 | Director | 1,000 | $71.09 | Sell | $71,090.00 | |
Oct. 4, 2017 | CEO | 80,000 | $70.14 | Sell | $5,611,200.00 | |
Oct. 4, 2017 | Insider | 10,470 | $70.00 | Sell | $732,900.00 | |
Oct. 2, 2017 | CEO | 6,000 | $66.76 | Sell | $400,560.00 | |
Oct. 2, 2017 | Insider | 2,146 | $67.23 | Sell | $144,275.58 | |
Sept. 18, 2017 | CEO | 35,000 | $67.12 | Sell | $2,349,200.00 | |
Sept. 14, 2017 | Director | 4,000 | $65.59 | Sell | $262,360.00 | |
Sept. 13, 2017 | Director | 1,000 | $65.47 | Sell | $65,470.00 | |
Sept. 11, 2017 | Insider | 15,000 | $65.00 | Sell | $975,000.00 | |
Sept. 1, 2017 | CEO | 6,000 | $62.20 | Sell | $373,200.00 | |
Sept. 1, 2017 | Insider | 2,146 | $61.99 | Sell | $133,030.54 | |
Aug. 23, 2017 | Director | 4,000 | $56.85 | Sell | $227,400.00 | |
Aug. 2, 2017 | CEO | 27,000 | $59.95 | Sell | $1,618,650.00 | |
Aug. 2, 2017 | Insider | 23,146 | $59.60 | Sell | $1,379,501.60 | |
July 20, 2017 | Director | 9,000 | $56.36 | Sell | $507,240.00 | |
July 19, 2017 | Director | 3,500 | $56.14 | Sell | $196,490.00 | |
July 7, 2017 | Insider | 2,146 | $55.00 | Sell | $118,030.00 | |
July 3, 2017 | CEO | 3,000 | $51.18 | Sell | $153,540.00 | |
June 21, 2017 | Insider | 4,292 | $55.00 | Sell | $236,060.00 | |
June 14, 2017 | Director | 2,000 | $50.87 | Sell | $101,740.00 | |
June 7, 2017 | CEO | 3,000 | $50.02 | Sell | $150,060.00 | |
May 25, 2017 | Director | 2,036 | $47.10 | Sell | $95,895.60 | |
May 1, 2017 | CEO | 3,000 | $50.06 | Sell | $150,180.00 | |
April 24, 2017 | Major Shareholder | 624,575 | $49.50 | Buy | $30,916,462.50 | |
April 18, 2017 | Director | 5,090 | $54.37 | Sell | $276,743.30 | |
April 17, 2017 | Director | 2,036 | $55.24 | Sell | $112,468.64 | |
April 3, 2017 | CEO | 3,000 | $58.62 | Sell | $175,860.00 | |
April 3, 2017 | Insider | 2,146 | $58.03 | Sell | $124,532.38 | |
March 23, 2017 | Director | 2,036 | $53.11 | Sell | $108,131.96 | |
March 20, 2017 | Insider | 6,438 | $55.00 | Sell | $354,090.00 | |
March 6, 2017 | Director | 40,599 | $50.84 | Sell | $2,064,053.16 | |
Feb. 28, 2017 | Director | 243,082 | $49.36 | Sell | $11,998,527.52 | |
Feb. 23, 2017 | Director | 135,364 | $49.37 | Sell | $6,682,920.68 | |
Feb. 16, 2017 | CEO | 6,000 | $50.01 | Sell | $300,060.00 |
Insiders are both buying and selling Agios Pharm stock.
The insider traders at Agios Pharm are: Scott Biller, David P Schenkein, Lewis Clayton Jr. Cantley, John Duncan Higgons, Glenn Goddard, Christopher Bowden, Steven L Hoerter, Theodore James Jr. Washburn, Brian Goff, Carman Alenson, Jacqualyn A Fouse, James William Burns, Cecilia Jones, Sarah Gheuens, Celgene European Investment Co, Kaye I Foster-Cheek, John Maraganore, Tsveta Milanova, Robert Nelsen, David Scadden, Darrin Miles, and Corp /De/ Celgene
The most active insider trader at Agios Pharm is Scott Biller with 46 trades.
David P Schenkein has sold the most Agios Pharm stock with a total value of $52,693,359.25.
Celgene European Investment Co has bought the most Agios Pharm stock with a total value of $112,876,552.75.
The most recent insider trade for Agios Pharm was on July 10, 2025.
The single biggest insider buy for Agios Pharm was from Corp /De/ Celgene with a total value of $57,027,318.00 on Jan. 23, 2018.
The single biggest insider sell for Agios Pharm was from Robert Nelsen with a total value of $11,998,527.52 on Feb. 28, 2017.